Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira Harrison-Woolrych

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Pharmacoepidemiology and Drug Safety|August 9, 2013
Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort studyMira Harrison-Woolrych, Helen Paterson, Ming Tan
BMJ Sexual & Reproductive Health|October 12, 2019
Pregnancies associated with etonogestrel implants in the UK: comparison of two 5-year reporting periodsSam Rowlands, Emma Cornforth, Mira Harrison-Woolrych
Pharmacoepidemiology and Drug Safety|August 6, 2003
Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena)Lifeng Zhou, Mira Harrison-Woolrych, David M Coulter
Pharmacoepidemiology and Drug Safety|July 31, 2007
Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring ProgrammeGeraldine R Hill, Janelle Ashton, Mira Harrison-Woolrych
The New Zealand Medical Journal|October 9, 2008
Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines useDesiree L Kunac, Mira Harrison-Woolrych, Michael V Tatley
Drug Safety|October 9, 2020
The Work of the Council for International Organizations of Medical Sciences (CIOMS) in Global PharmacovigilanceManal M Younus, Monika Zweygarth, Lembit Rägo, et al.
Drug Safety|July 3, 2007
Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort studyMira Harrison-Woolrych, Juan Garcia-Quiroga, Janelle Ashton, et al.
Drug Safety|May 9, 2020
The Role of Pharmacovigilance and ISoP During the Global COVID-19 PandemicRebecca E Chandler, Deirdre McCarthy, Jean-Christophe Delumeau, et al.
The International Journal of Pharmacy Practice|March 10, 2011
Electronic capture of dispensing data by the New Zealand Intensive Medicines Monitoring Programme: a consultation study of community and hospital pharmacistsMira Harrison-Woolrych, Simon Jamieson, Muzaffar Malik, et al.
Drug Safety|December 14, 2011
Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New ZealandMira Harrison-Woolrych, Simran Maggo, Ming Tan, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Pharmacoepidemiology and Drug Safety|August 9, 2013
Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort studyMira Harrison-Woolrych, Helen Paterson, Ming Tan
BMJ Sexual & Reproductive Health|October 12, 2019
Pregnancies associated with etonogestrel implants in the UK: comparison of two 5-year reporting periodsSam Rowlands, Emma Cornforth, Mira Harrison-Woolrych
Pharmacoepidemiology and Drug Safety|August 6, 2003
Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena)Lifeng Zhou, Mira Harrison-Woolrych, David M Coulter
Pharmacoepidemiology and Drug Safety|July 31, 2007
Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring ProgrammeGeraldine R Hill, Janelle Ashton, Mira Harrison-Woolrych
The New Zealand Medical Journal|October 9, 2008
Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines useDesiree L Kunac, Mira Harrison-Woolrych, Michael V Tatley
Drug Safety|October 9, 2020
The Work of the Council for International Organizations of Medical Sciences (CIOMS) in Global PharmacovigilanceManal M Younus, Monika Zweygarth, Lembit Rägo, et al.
Drug Safety|July 3, 2007
Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort studyMira Harrison-Woolrych, Juan Garcia-Quiroga, Janelle Ashton, et al.
Drug Safety|May 9, 2020
The Role of Pharmacovigilance and ISoP During the Global COVID-19 PandemicRebecca E Chandler, Deirdre McCarthy, Jean-Christophe Delumeau, et al.
The International Journal of Pharmacy Practice|March 10, 2011
Electronic capture of dispensing data by the New Zealand Intensive Medicines Monitoring Programme: a consultation study of community and hospital pharmacistsMira Harrison-Woolrych, Simon Jamieson, Muzaffar Malik, et al.
Drug Safety|December 14, 2011
Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New ZealandMira Harrison-Woolrych, Simran Maggo, Ming Tan, et al.
Pageof 5